A systematic review and meta-analysis of optical coherence tomography studies in schizophrenia, bipolar disorder and major depressive disorder

被引:8
|
作者
Prasannakumar, Akash [1 ]
Kumar, Vijay [1 ]
Mailankody, Pooja [2 ]
Appaji, Abhishek [3 ,4 ]
Battu, Rajani [5 ]
Berendschot, Tos T. J. M. [4 ]
Rao, Naren P. P. [1 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bangalore, Karnataka, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore, Karnataka, India
[3] BMS Coll Engn, Dept Med Elect, Bangalore, Karnataka, India
[4] Maastricht Univ, Univ Eye Clin Maastricht, Dept Opthalmol, Maastricht, Netherlands
[5] Ctr Eye Genet & Res, Dept Opthalmol, Bangalore, Karnataka, India
来源
关键词
Psychosis; retina; optical coherence tomography; mood disorder; NERVE-FIBER LAYER; GANGLION-CELL LAYER; STRUCTURE ABNORMALITIES; THICKNESS MEASUREMENT; MACULAR THICKNESS; VISUAL PATHWAYS; META-REGRESSION; RETINAL CHANGES; PERCEPTION; DECREASES;
D O I
10.1080/15622975.2023.2203231
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
ObjectivesDue to the common neurodevelopmental origin and easy accessibility, the retina serves as a surrogate marker for changes in the brain. Hence, Optical Coherence Tomography (OCT), a tool to examine the neuronal layers of retina has gained importance in investigating psychiatric disorders. Several studies in the last decade have reported retinal structural alterations in schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). However, the findings are inconsistent. Hence, we conducted a meta-analysis to investigate alterations in OCT parameters in patients with SCZ, BD and MDD.MethodsWe searched electronic databases for studies that examined OCT parameters in patients with SCZ, BD and MDD published up to January 2023. The primary outcome measures were thickness and volumes of the retinal Nerve Fibre Layer (RNFL). We conducted meta-analysis using a random effects model.ResultsThe searches yielded 2638 publications of which 43 studies were included in the final analysis across all disorders. Compared to controls, the RNFL was thinner in SCZ patients (SMD = -0.37, p = <0.001) and BD patients (SMD = -0.67, p = < 0.001), but not in MDD patients (SMD = -0.08, p = 0.54). On quadrant wise analysis, temporal quadrant RNFL was thinner in SCZ but not in BD, while all other quadrants were thinner in both SCZ and BD.ConclusionWe found significant reductions in RNFL thickness in SCZ and BD, but not in MDD. The differential involvement in various quadrants and parameters across the disorders has potential implications for using retinal parameters as a diagnostic biomarker.
引用
收藏
页码:707 / 720
页数:14
相关论文
共 50 条
  • [41] Weight changes in adults with major depressive disorder: A systematic review and meta-analysis of prospective studies
    Trevino-Alvarez, Andres Marcelo
    Sanchez-Ruiz, Jorge Andres
    Barrera, Francisco J.
    Rodriguez-Bautista, Mario
    Romo-Nava, Francisco
    McElroy, Susan L.
    Cuellar-Barbozaa, Alfredo B.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2023, 332 : 1 - 8
  • [42] Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis
    Le, Gia Han
    Wong, Sabrina
    Haikazian, Sipan
    Johnson, Danica E.
    Badulescu, Sebastian
    Kwan, Angela T. H.
    Gill, Hartej
    Vincenzo, Joshua D. Di
    Rosenblat, Joshua D.
    Mansur, Rodrigo
    Teopiz, Kayla M.
    Rhee, Taeho Greg
    Ho, Roger
    Liao, Sonya
    Cao, Bing
    Schweinfurth-Keck, Nina
    Vinberg, Maj
    Grande, Iria
    Phan, Lee
    d'Andrea, Giacomo
    Mcintyre, Roger S.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 365 : 381 - 399
  • [43] Risk of Mental Illness in Offspring of Parents with Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Meta-Analysis of Family High Risk Studies
    Uher, Rudolf
    Rasic, Daniel
    Hajek, Tomas
    Alda, Martin
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 172S - 172S
  • [44] Neuroimaging hippocampal subfields in schizophrenia and bipolar disorder: A systematic review and meta-analysis
    Haukvik, Unn K.
    Tamnes, Christian K.
    Soderman, Erik
    Agartz, Ingrid
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 217 - 226
  • [45] Copper in depressive disorder: A systematic review and meta-analysis of observational studies
    Ni Mengmei
    You Yiping
    Chen Jinyao
    Zhang Lishi
    [J]. PSYCHIATRY RESEARCH, 2018, 267 : 506 - 515
  • [46] Meta-analysis of genetic studies in major depressive disorder
    Cecile, A.
    Janssens, J. W.
    Leon, Sandra Lopez
    Ladd, Angela M. Gonzalez-Zuloeta
    Del-Favero, Jurgen
    Claes, Stephan
    Oostra, Ben A.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 693 - 693
  • [47] A meta-analysis of the risk of major affective disorder in relatives of individuals affected by major depressive disorder or bipolar disorder
    Wilde, A.
    Chan, H. -N.
    Rahman, B.
    Meiser, B.
    Mitchell, P. B.
    Schofield, P. R.
    Green, M. J.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2014, 158 : 37 - 47
  • [48] Kynurenic Acid Levels in Major Depressive Disorder: A Systematic Review and Meta-Analysis
    Nakajima, Shinichiro Luke
    Ogyu, Kamiyu
    Kubo, Kaoruhiko
    Iwata, Yusuke
    Noda, Yoshihiro
    Plitman, Eric
    Moriguchi, Sho
    Tsugawa, Sakiko
    Omura, Yuki
    Uchida, Hiroyuki
    Graff-Guerrero, Ariel
    Mimura, Masaru
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S344 - S344
  • [49] A systematic review and meta-analysis of cognitive training in adults with Major Depressive Disorder
    Woolf, Claudia
    Lampit, Amit
    Shahnawaz, Zeeshan
    Sabates, Julieta
    Norrie, Louisa
    Burke, David
    Naismith, Sharon
    Mowszowski, Loren
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2020, 32 : 191 - 191
  • [50] Vortioxetine versus venlafaxine for major depressive disorder: A meta-analysis and systematic review
    Maneeton, B.
    Maneeton, N.
    Woottiluk, P.
    Oonarom, A.
    Wiriyacosol, P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S45 - S45